Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-13-004464
Filing Date
2013-08-14
Accepted
2013-08-14 06:59:55
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 2011 10K AMENDMENT cbmg_10ka.htm 10-K/A 1346945
2 img001.jpg GRAPHIC 17834
3 CERTIFICATION cbmg_311.htm EX-31.1 15261
4 CERTIFICATION cbmg_312.htm EX-31.2 15235
5 CERTIFICATION cbmg_321.htm EX-32.1 6558
6 CERTIFICATION cbmg_322.htm EX-32.2 6490
  Complete submission text file 0001354488-13-004464.txt   4185411

Data Files

Seq Description Document Type Size
7 ebig-20111231.xml EX-101.INS 384294
8 ebig-20111231.xsd EX-101.SCH 16125
9 ebig-20111231_cal.xml EX-101.CAL 27901
10 ebig-20111231_lab.xml EX-101.LAB 97641
11 ebig-20111231_pre.xml EX-101.PRE 74405
12 ebig-20111231_def.xml EX-101.DEF 17129
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52282 | Film No.: 131034909
SIC: 6199 Finance Services